The impact of genetic and environmental factors on the pathobiology of Alzheimer's disease: a multifactorial disorder?

References

• Abdel-Ghany M., El-Sebae A.K., Shalloway D. Aluminum-induced nonenzymatic phospho-incorporation into human cau and other proteins. Journal of Biological Chemistry 1993; 268: 11976–11981
   Google Scholar
• Alzheimer's Disease Research Group. Molecular classification of Alzheimer's disease. Lancet 1991; 337: 1342–1343
   Google Scholar
• Arai H., Terajima M., Miura M., Higuchi S., Muramatsu T., Machida N., Seiki H., Takase S., Clark C.M., Lee V. M.-Y., Trojanowski J.Q., Sasaki H. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Annals of Neurology 1995; 38: 649–652
   PubMed Web of Science ®Google Scholar
• Arriagada P.W., Growdon J.H., Hedley-White E.T., Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992; 42: 631–639
   PubMed Web of Science ®Google Scholar
• Ashall F., Goate A.M. Role of the β-amyloid precursor protein in Alzheimer's disease. Trends in Biochemical Sciences 1994; 19: 42–46
   PubMed Web of Science ®Google Scholar
• Baker F.M., Jordan B., Barclay L., Schoenberg B.S. Risk factors for clinically diagnosed Alzheimer's disease. International Journal of Geriatric Psychiatry 1993; 8: 379–385
   Google Scholar
• Barger S.W., Horster D., Furukawa K., Goodman Y., Krieglstein J., Mattson M.P. Tumor necrosis factors x and β protect neurons against amyloid β-peptide toxicity: evidence for involvement of kB-binding factor and attenuation of peroxide and Ca2+ accumulation. Proceedings of the National Academy of Sciences, USA 1995; 92: 9328–9332
   PubMed Web of Science ®Google Scholar
• Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Annals of Neurology 1995; 38: 257–266
   Google Scholar
• Behl C., Davis J., Cole G.M., Schubert D. Vitamin E protects nerve cells from amyloid protein toxicity. Biochemical and Biophysical Research Communications 1992; 186: 944–950
   PubMed Web of Science ®Google Scholar
• Benjamin R., Leake A., Ince P.G., Perry R.H., McKeith I.G., Edwardson J.A., Morris C.M. Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body type and Alzheimer's disease. Neurodegeneration 1995; 4: 443–448
   Google Scholar
• Blass J.P., Baker A.C., Ko L.-W., Black R.S. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Archives of Neurology 1990; 47: 864–869
   PubMedGoogle Scholar
• Bondareff W., Harrington C.R., Wischik C.M., Hauser D.L., Roth M. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 1995; 54: 657–663
   PubMedGoogle Scholar
• Bondareff W., Wischik C.M., Novak M., Roth M. Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease. American Journal of Pathology 1991; 139: 641–647
   Google Scholar
• Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991; 82: 239–259
   PubMed Web of Science ®Google Scholar
• Brayne C., Harrington C.R., Wischik C.M., Huppert F.A., Chi L.Y., Xuereb J.H., O'Connor D.W., Paykel E.S. Apolipo-protein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia 1996; 1, in press
   Google Scholar
• Breitner J.C.S., Welsh K.A. Genes and recent developments in the epidemiology of Alzheimer's disease and related dementia. Epidemiological Reviews 1995; 17: 39–47
   Google Scholar
• Breitner J.C.S., Welsh K.A., Gau B.A., McDonald L.V.M., Steffens D.C., Saunders A.M., Magruder K.M., Helms M.J., Plassman B.L., Folstein M.F., Brandt J., Robinette C.D., Page W.F. Alzheimer's disease in the National Academy of Sciences—National Research Council Registry of aging twin veterans. III. Detection of cases, longitudinal results, and observations of twin concordance. Archives of Neurology 1995; 52: 763–771
   PubMedGoogle Scholar
• Bugiani O., Brancaccio D., Ghetti B. Progressive dialytic encephalopathy and the problem of aluminum neurotoxicity. Clinical Nephrology 1985; 24: S20–S25
   Google Scholar
• Butner K.A., Kirschner M.W. Tau protein binds to microtubules through a flexible array of distributed weak sites. Journal Cell Biology 1991; 115: 717–730
   PubMed Web of Science ®Google Scholar
• Butterfield D.A., Hensley K., Harris M., Mattson M., Carney J. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochemical and Biophysical Research Communications 1994; 200: 710–715
   PubMed Web of Science ®Google Scholar
• Candy J.M., Klinowski J., Perry R.H., Perry E.K., Fairbairn A., Oakley A.E., Carpenter T.A., Atack J.R., Blessed G., Edwardson J.A. Aluminosilicate and senile plaque formation in Alzheimer's disease. Lancet 1986; i: 354–356
   Google Scholar
• Chartier-Harlin M.-C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J., Mullan M. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991; 353: 844–846
   PubMed Web of Science ®Google Scholar
• Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P. C., Jr., Rimmler J.B., Locke P.A., Conneally P.M., Schmader K.A., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Protective effect of apolipoprotein E type 2 allele for late onset alzheimer disease. Nature Genetics 1994; 7: 180–183
   PubMed Web of Science ®Google Scholar
• Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–923
   PubMed Web of Science ®Google Scholar
• Corral-Debrinski M., Horton T., Lott M.T., Shoffner J.M., McKee A.C., Beal M.F., Graham B.H., Wallace D.C. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 1994; 23: 471–476
   PubMedGoogle Scholar
• Corsellis J.A.N., Bruton C.J., Freeman-Browne D. The aftermath of boxing. Psychological Medicine 1973; 3: 270–303
   PubMed Web of Science ®Google Scholar
• Crowther R.A., Olesen O.F., Jakes R., Goedert M. The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease. FEBS Letters 1992; 309: 199–202
   PubMed Web of Science ®Google Scholar
• Crystal H., Dickson D., Fuld P., Masur D., Scott R., Mehler M., Masdew J., Kwas C., Aronson M., Wolfson L. Clinico-pathologic studies in dementia: non-demented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988; 38: 1682–1687
   PubMed Web of Science ®Google Scholar
• Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1–21
   PubMedGoogle Scholar
• Delaere P., He Y., Fayet G., Duyckaerts C., Hauw J.-J. βA4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians. Neurobiology of Aging 1993; 14: 191–194
   PubMedGoogle Scholar
• Dickson D.W., Crystal H., Mattiace L.A., Kress Y., Schwageri A., Ksiezak-Reding H., Davies P., Yen S.-H. Diffuse Lewy body disease: light and electron microscopic immunohistochemistry of senile plaques. Acta Neuropathologica 1989; 78: 572–584
   PubMedGoogle Scholar
• Dickson D.W., Ruan D., Crystal H., Mark M.H., Davies P., Kress Y., Yen S.-H. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocyto-chemistry of CA2–3 neurites specific to DLBD. Neurology 1991; 41: 1402–1409
   PubMed Web of Science ®Google Scholar
• Dickson D.W., Schmidt M.L., Lee V.M.Y., Zhao M.-L., Yen S.-H., Trojanowski J.Q. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathology 1994; 87: 269–276
   PubMed Web of Science ®Google Scholar
• Doll R. Alzheimer's disease and environmental aluminium. Age and Aging 1993; 22: 138–153
   PubMedGoogle Scholar
• Drewes G., Trinczek B., Illenberger S., Biernat J., Schmitt-Ulms G., Meyer H.E., Mandlkow E.-M., Mandelkow E. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation of the Alzheimer-specific site serine 262. Journal of Biological Chemistry 1995; 270: 7679–7688
   PubMed Web of Science ®Google Scholar
• Dudek S.M., Johnson G.V.W. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau. Journal of Neurochemistry 1993; 61: 1159–1162
   Google Scholar
• Dyrks T., Dyrks E., Hartmann T., Masters C.L., Beyreuther K. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. Journal of Biological Chemistry 1992; 267: 18210–18217
   PubMed Web of Science ®Google Scholar
• Elkelenboom P., Zhan S.-S., Van Gool W.A., Allsop D. Inflammatory mechanisms in Alzheimer's disease. Trends in Pharmacological Sciences 1994; 15: 447–450
   Google Scholar
• Exley C., Price N.C., Kelly S.M., Birchall J.D. An interaction of β-amyloid with aluminium in vitro. FEBS Letters 1993; 324: 293–295
   PubMed Web of Science ®Google Scholar
• Fasman G.D., Moore C.D. The solubilization of model Alzheimer tangles: reversing the β-sheet conformation induced by aluminum with silicates. Proceedings of the National Academy of Sciences, USA 1994; 91: 11232–11235
   PubMedGoogle Scholar
• Fasman G.D., Perczel A., Moore C.D. Solubilization of β-amyloid-(1–42)-peptide: reversing the β-sheet conformation induced by aluminum with silicates. Proceedings of the National Academy of Sciences, USA 1995; 92: 369–371
   PubMedGoogle Scholar
• Feskens E.J.M., Havekes L.M., Kalmijn S., DeKnijff P., Launer L.J., Kromhout D. Apolipoprotein ε4 allele and cognitive decline in elderly men. British Medical Journal 1994; 309: 1202–1206
   PubMed Web of Science ®Google Scholar
• Frisoni G.B., Calabresi L., Geroldi C., Bianchetti A., D'Acquarica A.L., Govoni S., Sirtori C.R., Trabucchi M., Franceschini G. Apoliporprotein E ε4 allele in Alzheimer's disease and vascular dementia. Dementia 1994; 5: 240–242
   Google Scholar
• Gabuzda D., Busciguo J., Chen L.B., Matsudaira P., Yankner B.A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. Journal of Biological Chemistry 1994; 269: 13623–13628
   PubMed Web of Science ®Google Scholar
• Galasko D., Saitoh T., Xia Y., Thal L.J., Katzman R., Hill L.R., Hansen L. The apolipoprotein E allele ε4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44: 1950–1951
   Web of Science ®Google Scholar
• Games D., Adams D., Allessandrini R., Barbour R., Berthelette P., Blackwell C., Carr J., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowttz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Suebert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F -amyloid precursor protein. Nature 1995; 373: 523–527
   PubMed Web of Science ®Google Scholar
• Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704–706
   PubMed Web of Science ®Google Scholar
• Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends in Neurosciences 1993; 16: 460–465
   PubMed Web of Science ®Google Scholar
• Goode B.L., Feinstein S.C. Identification of a normal microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau. Journal of Cell Biology 1994; 124: 769–782
   Google Scholar
• Griffin W.S.T., Stanley L.C., Ung C., White L., Macleod V., Perrot L.J., White C. L., III., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1989; 86: 7611–7615
   PubMed Web of Science ®Google Scholar
• Gustke N., Steiner B., Mandelkow E.-M., Biernat J., Meyer H.E., Goedert M., Mandelkow E. The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Letters 1992; 307: 199–205
   PubMed Web of Science ®Google Scholar
• Guy S.P., Jones D., Mann D.M.A., Itzhaki R.F. Human neuroblastoma cells treated with aluminium express an epitope associated with Alzheimer's disease neurofibrillary tangles. Neuroscience Letters 1991; 121: 166–168
   Google Scholar
• Hajimohammadreza I., Brammer M.J., Eagger S., Burns A., Levy R. Platelet and erythrocyte membrane changes in Alzheimer's disease. Biochimica et Biophysica Acta 1990; 1025: 208–214
   PubMed Web of Science ®Google Scholar
• Hansen L.A., Galasko D. Lewy body disease. Current Opinion in Neurology and Neurosurgery 1992; 5: 889–894
   PubMedGoogle Scholar
• Harada A., Oguchi K., Okabe S., Kuno J., Terada S., Ohshima T., Sato-Yoshitake R., Takei Y., Noda T., Hirokawa N. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 1994; 369: 488–491
   PubMed Web of Science ®Google Scholar
• Harrington C.R., Colaco C. A. L. S. Alzheimer's disease: a glycation connection. Nature 1994; 370: 247–248
   PubMed Web of Science ®Google Scholar
• Harrington C.R., Edwards P.C., Wischik C.M. Competitive ELISA for measurement of tau proteins in Alzheimer's disease. Journal of Immunological Methods 1990; 134: 261–271
   Google Scholar
• Harrington C.R., Mukaetova-Ladinska E.B., Hills R., Edwards P.C., Montejo De Garcini E., Novak M., Wischik C.M. Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1991; 88: 5842–5846
   Google Scholar
• Harrington C.R., Perry R.H., Perry E.K., Hurt J., McKeith I.G., Roth M., Wischik C.M. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 1994a; 5: 215–228
   PubMedGoogle Scholar
• Harrington C.R., Louwagie J., Rossau R., Vanmechelen E., Perry R.H., Perry E.K., Xuereb J.H., Roth M., Wischik C.M. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. American Journal of Pathology 1994b; 145: 1472–1484
   Google Scholar
• Harrington C.R., Wischik C.M., McArthur F.K., Taylor G.A., Edwardson J.A., Candy J.M. Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Lancet 1994c; 343: 993–997
   PubMedGoogle Scholar
• Harrington C.R., Roth M., McKenna P.J., Wischik C.M. Apolipoprotein E type ε4 allele frequency is increased in patients with schizophrenia. Neuroscience Letters 1995; 202: 101–104
   PubMed Web of Science ®Google Scholar
• Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by die peptide: relevance to Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1994; 91: 3270–3274
   PubMed Web of Science ®Google Scholar
• Hock C., Golombowski S., Naser W., Müller-Spahn F. Increased levels of protein in cerebrospinal fluid of patients with Alzheimer's disease—correlation with degree of cognitive impairment. Annals of Neurology 1995; 37: 414–415
   Google Scholar
• Horwitz B., Grady C.L., Schlageter N.L., Duara R., Rapoport S.I. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease. Brain Research 1987; 407: 294–306
   PubMed Web of Science ®Google Scholar
• Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathologic study of 100 cases. Journal of Neurology, Neurosurgery and Psychiatry 1992; 55: 181–184
   PubMed Web of Science ®Google Scholar
• Hutchin T., Cortopassi G. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1995; 92: 6892–6895
   PubMedGoogle Scholar
• Iwatsubo T., Mann D.M.A., Odaka A., Suzuki N., Ihara Y. Amyloid protein (A) deposition: A 42(43) precedes A 40 in Down syndrome. Annals of Neurology 1995; 37: 294–299
   PubMed Web of Science ®Google Scholar
• Iizuku T., Shoji M., Harigaya Y., Kawarabayashi T., Watanabe M., Kanai M., Hirai S. Amyloid β-protein ending at Thr43 is a minor component of some diffuse plaques in die AD brain, but is not found in cerebrovascular amyloid. Brain Research 1995; 702: 275–278
   Google Scholar
• Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43) and Aβ40 and senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 1994; 13: 45–53
   PubMed Web of Science ®Google Scholar
• Jakes R., Novak M., Davison M., Wischik C.M. Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease. EMBO Journal 1991; 10: 2725–2729
   PubMed Web of Science ®Google Scholar
• Jarrett J.T., Berger E.P., Lansbury P. T., Jr. The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993; 32: 4693–4697
   PubMed Web of Science ®Google Scholar
• Jensen M., Basun H., Lannfelt L. Increased cerebrospinal fluid tau in patients with Alzheimer's disease. Neuroscience Letters 1995; 186: 189–191
   PubMed Web of Science ®Google Scholar
• Kamboh M.I., Sanghera D.K., Ferrell R.E., DeKosky S.T. APOE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nature Genetics 1995; 10: 486–488
   PubMed Web of Science ®Google Scholar
• Kawahara M., Muramoto K., Kobayashi K., Kuroda Y. Functional and morphological changes in cultured neurons of rat cerebral cortex induced by long-term application of aluminium. Biochemical and Biophysical Research Communications 1992; 189: 1317–1322
   Google Scholar
• Kawahara M., Muramoto K., Kobayasm K., Mori H., Kuroda Y. Aluminium promotes the aggregation of Alzheimer's β-protein in vitro. Biochemical and Biophysical Research Communications 1994; 198: 531–535
   PubMed Web of Science ®Google Scholar
• Klatzo I., Wisniewski H., Streicher E. Experimental production of neurofibrillary degeneration. 1. Light microscopic observation. Journal of Neuropathology and Experimental Neurology 1965; 24: 187–199
   PubMed Web of Science ®Google Scholar
• Koller W.C., Glatt S.L., Hubble J.P., Paolo A., Tröster A.I., Handler M.S., Horvat R.T., Martin C., Schmidt K., Karst A., Wijsman E.M., Yu C.-E., Schellenberg G.D. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Neurology 1995; 37: 242–245
   Google Scholar
• Kondo J., Honda T., Mori H., Hamada Y., Miura R., Ogawara M., Ihara Y. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1988; 1: 827–834
   PubMedGoogle Scholar
• Kumar A., Schapiro M.B., Grady C.L., et al. Anatomic, metabolic, neuropsychological, and molecular genetic studies of three pairs of identical twins discordant for dementia of the Alzheimer's type. Archives of Neurology 1991; 48: 160–168
   Google Scholar
• Kuusisto J., Korvisto K., Kervinen K., Mykkänen L., Helkala E.-L., Vanhanen M., Hänninen T., Pyörälä K., Kesäniemi Y.A., Riekkinen P., Laakso M. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. British Medical Journal 1994; 309: 636–638
   PubMedGoogle Scholar
• Lai R.Y.K., Gertz H.-J., Wischik D.J., Xuereb J.H., Mukaetova-Ladinska E.B., Harrington C.R., Edwards P.C., Paykel E.S., Brayne C., Huppert F.A., Roth M., Wischik C.M. Examination of phosphorylated tau protein as a PHF-precursor at early stage Alzheimer's disease. Neurobiology of Aging 1995; 16: 433–445
   Google Scholar
• Lantos P., Ovenstone I.M.K., Johnson J., Clelland C.A., Roques P., Rossor M.N. Lewy bodies in the brain of two members of a family with the 717 (Val to IIe) mutation of the amyloid precursor protein gene. Neuroscience Letters 1994; 172: 77–79
   Google Scholar
• Lantos P.L., Luthert P.J., Anderton B.H., Mullan M., Rossor M. Familial Alzheimer's disease with amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neuroscience Letters 1992; 137: 221–224
   Google Scholar
• Ledesma M.D., Bonay P., Avila J. Protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. Journal of Neurochemistry 1995; 65: 1658–1664
   PubMed Web of Science ®Google Scholar
• Ledesma M.D., Bonay P., Colaco C., Avila J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. Journal of Biological Chemistry 1994; 269: 21614–21619
   PubMed Web of Science ®Google Scholar
• Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.B., Lieberburg I., Van Duinen S.G., Bots G. T.A. M., Luyendijk W., Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral haemorrhage, Dutch type. Science 1990; 248: 1124–1126
   PubMed Web of Science ®Google Scholar
• Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.-E., Jondro P.D., Schmidt S.D., Wang K., Crowley A.C., Fu Y.-H., Guenette S.Y., Galas D., Nemens E., Wijsman E.M., Bird T.D., Schellengberg G.D., Tanzi R.E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973–977
   PubMed Web of Science ®Google Scholar
• Linnane A.W., Marzuki S., Ozawa T., Tanaka M. Mitochondrial DNA mutations as an important contribution to aging and degenerative diseases. Lancet 1989; i: 642–645
   Google Scholar
• Lowe J. Lewy bodies. Neurodegenerative Diseases, D.B. Calne. W. B. Saunders, Philadelphia 1994; 51–69
   Google Scholar
• Maciver S.K., Harrington C.R. Two actin binding proteins, actin depolymerising factor and cofilin, are associated with Hirano bodies in Alzheimer's disease. Neuro Report 1995; 6: 1985–1988
   Google Scholar
• Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622–630
   PubMed Web of Science ®Google Scholar
• Maillard L.C. Action des acides amines sur les sucres; formation des melanoidines par voie methodique. Comptes Rendus hebdomadaires des séances de l'Académie des Sciences 1912; 154: 66–68
   Google Scholar
• Mann D.M.A., Jones D., Snowdon J.S., Neary D., Hardy J. Pathological changes in the brain of a patient with familial Alzheimer's disease having a missense mutation at codon 717 in the amyloid precursor protein gene. Neuroscience Letters 1992; 137: 225–228
   Google Scholar
• Mantyh P.W., Ghilardi J.R., Rogers S., de Master E., Allen C.J., Stimson E.R., Maggio J.E. Aluminium, iron, and zinc ions promote aggregation of physiological concentrations of β-amytoid peptide. Journal of Neurochemistry 1993; 61: 1171–1174
   PubMed Web of Science ®Google Scholar
• Marder K., Maestre G., Cote L., Mejia H., Alfaro B., Halim A., Tang M., Tycko B., Mayeux R. The apolipoprotein ε4 allele in Parkinson's disease with and without dementia. Neurology 1994; 44: 1330–1331
   PubMed Web of Science ®Google Scholar
• Matsuo E.S., Shin R.-W., Billingsley M.L., Van DeVoorde A., O'Connor M., Trojanowski J.Q., Lee V. M.-Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994; 13: 989–1002
   PubMedGoogle Scholar
• McGeer P.L., Rogers J., McGeer E.G. Neuroimmune mechanisms in Alzheimer's disease pathogenesis. Alzheimer's Disease and Associated Disorders 1994; 8: 149–158
   PubMed Web of Science ®Google Scholar
• McKeith I.G., Perry R.H., Perry E.K. Dementia with Lewy bodies: clinical, pathological and therapeutic aspects. Cambridge University Press. 1996, in press
   Google Scholar
• Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Annals of Neurology 1994; 36: 747–751
   PubMed Web of Science ®Google Scholar
• Mena R., Edwards P., Pérez-Olvera O., Wischik C.M. Monitoring pathological assembly of tau and β-amyloid proteins in Alzheimer's disease. Acta Neuropathologica 1995; 89: 50–56
   Google Scholar
• Mesco E.R., Kachen C., Timiras P.S. Effects of aluminum on tau proteins in human neuroblastoma cells. Molecular and Chemical Neuropathology 1991; 14: 199–212
   Google Scholar
• Miller M.L., Johnson G.V.W. Transglutaminase cross-linking of die protein. Journal of Neurochemistry 1995; 65: 1760–1770
   PubMed Web of Science ®Google Scholar
• Mori H., Hosoda K., Matsubara E., Nakamoto T., Furiya Y., Endoh R., Usami M., Shoji M., Maruyama S., Hirai S. Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau. Neuroscience Letters 1995; 186: 181–183
   PubMed Web of Science ®Google Scholar
• Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Titani K., Ihara Y. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 1993; 10: 1151–1160
   PubMed Web of Science ®Google Scholar
• Motter R., Vigo-Pelfrey C., Kholodenko D., Barbour R., Johnson-Wood K., Galasko D., Chang L., Miller B., Clark C., Green R., Olson D., Soutwick P., Wolfert R., Munroe B., Lieberburg I., Seubert P., Schenk D. Reduction of (-amyloid peptide 42 in the cerebrospinal fluid with Alzheimer's disease. Annals of Neurology 1995; 38: 643–648
   PubMed Web of Science ®Google Scholar
• Mukaetova-Ladinska E.B., Harrington C.R., Hills R., O'Sullivan A., Roth M., Wischik C.M. Regional distribution of paired helical filaments and normal tau proteins in aging and in Alzheimer's disease with and without occipital lobe involvement. Dementia 1992; 3: 61–69
   Google Scholar
• Mukaetova-Ladinska E.B., Harrington C.R., Roth M., Wischik C.M. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. American Journal of Pathology 1993; 143: 565–578
   PubMed Web of Science ®Google Scholar
• Mukaetova-Ladinska E.B., Harrington C.R., Roth M., Wischik C.M. Alterations in tau protein metabolism during normal aging. Dementia 1995; 7: 95–103
   Google Scholar
• Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at die N-terminus of β-amyloid. Nature Genetics 1992; 1: 345–347
   PubMed Web of Science ®Google Scholar
• Munroe W.A., Southwick P.C., Chang L., Scharre D.W., Echols C.L., Fu P.C., Whaley J.M., Wolfert R.L. Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease. Annals of Clinical and Laboratory Sciences 1995; 25: 207–217
   Google Scholar
• Murrell J., Farlow M., Ghetti B., Benson M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991; 253: 97–98
   Google Scholar
• Nathan B.P., Bellosta C., Sanan D.A., Weisgraber K.H., Mahley R.W. Differential effects of apolipoproteins E3 and ε4 on neuronal growth in vitro. Science 1994; 264: 850–852
   PubMed Web of Science ®Google Scholar
• Nicoll J.A.R., Roberts G.W., Graham D.I. Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury. Nature Medicine 1995; 1: 135–137
   PubMed Web of Science ®Google Scholar
• Nitsch R.M., Rebeck G.W., Deng M., Richardson U.I., Tennis M., Schenk D.B., Vigo-Pelfrey C., Lieberburg I., Wurtman R.J., Hyman B.T., Growdon J.H. Cerebrospinal fluid levels of amyloid β-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype. Annals of Neurology 1995; 37: 512–518
   PubMed Web of Science ®Google Scholar
• Noguchi S., Murukami K., Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342: 737
   Google Scholar
• Novak M., Kabat J., Wischik C.M. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO Journal 1993; 12: 365–370
   PubMed Web of Science ®Google Scholar
• Okuizumi K., Onodera O., Namba Y., Ikeda K., Yamamoto T., Seki K., Ueki A., Nanko S., Tanaka H., Takahashi H., Oyanagi K., Mizusawa H., Kanazawa I., Tsuji S. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature Genetics 1995; 11: 207–209
   PubMedGoogle Scholar
• Oliver C., Holland A.J. Down's syndrome and Alzheimer's disease: a review. Psychological Medicine 1986; 16: 307–322
   PubMed Web of Science ®Google Scholar
• Pan K.-M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., Prusiner S.B. Conversion of α-helices into β-sheets features in the formation of scrapie prion proteins. Proceedings of the National Academy of Sciences, USA 1993; 90: 10962–10966
   PubMed Web of Science ®Google Scholar
• Perl D.P., Brody A.R. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurones. Science 1980; 208: 297–299
   PubMed Web of Science ®Google Scholar
• Perry R.H., Irving D., Blessed G., Fairbairn A., Perry E.K. Senile dementia of the Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. Journal of Neurological Sciences 1990; 95: 119–139
   PubMed Web of Science ®Google Scholar
• Perry E.K., Perry R.H. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain and Cognition 1995; 28: 240–258
   PubMed Web of Science ®Google Scholar
• Petersen R.C., Smith G.E., Ivnik R.J., Tangalos E.G., Schaid D.J., Thibodeau S.N., Waring S.C., Kurland L.T. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. Journal of the American Medical Association 1995; 273: 1273–1278
   Google Scholar
• Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends in Neurosciences 1994; 17: 525–530
   PubMed Web of Science ®Google Scholar
• Pollanen M.S., Dickson D.W., Bergeron C. Pathology and biology of the Lewy body. Journal of Neuropathology and Experimental Neurology 1993; 52: 183–191
   PubMed Web of Science ®Google Scholar
• Prusiner S.B. Biology and genetics of prion diseases. Annual Reviews of Microbiology 1994; 48: 655–686
   PubMed Web of Science ®Google Scholar
• Roberts G.W., Allsop D., Bruton C. The occult aftermath of boxing. Journal of Neurology, Neurosurgery and Psychiatry 1990; 53: 373–378
   PubMed Web of Science ®Google Scholar
• Roberts G.W., Gentleman S.M., Lynch A., Graham D.I. βA4 amyloid protein deposition in brain after head trauma. Lancet 1991; 338: 1422–1423
   PubMed Web of Science ®Google Scholar
• Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Wang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D., Lannfelt L., Fraser P.E., Rommens J.M., St. George-Hyslop P.H. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376: 775–778
   PubMed Web of Science ®Google Scholar
• Roses A.D. Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. Journal of Neuropathology and Experimental Neurology 1994; 53: 429–437
   PubMed Web of Science ®Google Scholar
• Royston M.C., Rothwell N.J., Roberts G.W. Alzheimer's disease: pathology to potential treatments?. Trends in Pharmacological Sciences 1992; 13: 131–133
   PubMed Web of Science ®Google Scholar
• Saunders A.M., Strittmatter W.J., Schmechel D., St. George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-McLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467–1472
   PubMed Web of Science ®Google Scholar
• Savory J., Huang Y., Herman M.H., Reyes M.R., Wills M.R. Tau immunoreactiviry associated with aluminum maltolate-induced neurofibrillary degeneration in rabbits. Brain Research 1995; 669: 325–329
   Google Scholar
• Schellenberg G.D. Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proceedings of the National Academy of Sciences, USA 1995; 92: 8552–8559
   PubMed Web of Science ®Google Scholar
• Schweers O., Mandelkow E.-M., Biernat J., Mandelkow E. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein controls the in vitro assembly of paired helical filaments. Proceedings of the National Academy of Sciences, USA 1995; 92: 8463–8467
   PubMed Web of Science ®Google Scholar
• Selkoe D.J. Normal and abnormal biology of the β-amyloid precursor protein. Annual Reviews of Neuroscience 1994; 17: 489–517
   PubMed Web of Science ®Google Scholar
• Shearman M.S., Ragan C.I., Iversen L.L. Inhibition of PC 12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proceedings of the National Academy of Sciences, USA 1994; 91: 1470–1474
   PubMed Web of Science ®Google Scholar
• Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., DaSilva H.A.R., Haines J.L., Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., St. George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754–760
   PubMed Web of Science ®Google Scholar
• Shin R.-W., Lee V. M.-Y., Trojanowski J.Q. Aluminum modifies the properties of Alzheimer's disease PHFτ proteins in vivo and in vitro. Journal of Neuroscience 1994; 14: 7221–7233
   PubMedGoogle Scholar
• Shoffner J.M., Brown M.D., Torroni A., Lott M.T., Cabell M.F., Mirra S.S., Beal M.F., Yang C.-C., Gearing M., Salvo R., Watts R.L., Juncos J.L., Hansen L.A., Crain B.J., Fayad M., Reckord C.L., Wallace D.C. Mitochondrial DNA variants observed in Alzheimer's disease and Parkinson's disease patients. Genomics 1993; 17: 171–184
   PubMed Web of Science ®Google Scholar
• Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1991; 88: 10540–10543
   PubMed Web of Science ®Google Scholar
• Smith M.C., Mallory M., Hansen L.A., Ge N., Masliah E. Fragmentation of the neuronal cytoskeleton in the Lewy body variant of Alzheimer's disease. Neuro Report 1995; 6: 673–676
   Google Scholar
• Stadtman E.R. Protein oxidation and aging. Science 1992; 257: 1220–1224
   PubMed Web of Science ®Google Scholar
• Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Science, USA 1993a; 90: 1977–1981
   PubMed Web of Science ®Google Scholar
• Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.-M., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1993b; 90: 8098–8102
   PubMed Web of Science ®Google Scholar
• Strittmatter W.J., Saunders A.M., Goedert M., Weisgraber K.H., Dong L.-M., Jakes R., Huang D.Y., Pericak-Vance M., Schmechel D., Roses A.D. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1994; 91: 11183–11186
   PubMed Web of Science ®Google Scholar
• Subbarao K.V., Richardson J.S., Ang L.C. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. Journal of Neurochemistry 1990; 55: 342–345
   PubMed Web of Science ®Google Scholar
• Suzuki N., Iwatsubo T., Odaka A., Ishibashi Y., Kitada C., Ihara Y. High tissue content of soluble β-40 is linked to cerebral amyloid angiopathy. American Journal of Pathology 1994; 145: 452–460
   PubMed Web of Science ®Google Scholar
• Takashima A., Noguchi K., Sato K., Hoshino T., Imahori K. Tau protein kinase I is essential for amyloid β-protein induced neurotoxicity. Proceedings of the National Academy of Sciences, USA 1993; 90: 7789–7793
   PubMed Web of Science ®Google Scholar
• Tato R.E., Frank A., Hernanz A. Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type. Journal of Neurology, Neurosurgery and Psychiatry 1995; 59: 280–283
   PubMedGoogle Scholar
• Telling G.C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F.E., DeArmond S.J., Prusiner S.B. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83: 79–90
   PubMed Web of Science ®Google Scholar
• Terry R.D., Pena C. Experimental production of neurofibrillary degeneration. 2. Electron microscopy, phosphatase histochemistry and electron probe analysis. Journal of Neuropathology and Experimental Neurology 1965; 24: 200–210
   PubMed Web of Science ®Google Scholar
• Troncoso J.C., Costello A., Watson A. L., Jr., Johnson G.V.W. In vitro polymerization of oxidised tau into filaments. Brain Research 1993; 613: 313–316
   PubMedGoogle Scholar
• Ueda K., Fukui Y., Kageyama H. Compromise of mitochondrial function induced by amyloid β-protein in PC 12 cells and protection by cyclic AMP-dependent protein kinase inhibitors. Neuroscience Research Communications 1994; 15: 200
   Google Scholar
• Vandermeeren M., Mercken M., Vanmechelen E., Six J., Van De Voorde A., Martin J.-J., Cras P. Detection of τ proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. Journal of Neurochemistry 1993; 61: 1828–1834
   PubMed Web of Science ®Google Scholar
• Van Duijn C.M., de Knijff P., Cruts M., Wehnert A., Havekes L.M., Hofman A., Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early onset Alzheimer's disease. Nature Genetics 1994; 7: 74–78
   PubMed Web of Science ®Google Scholar
• Vigo-Pelfrey C., Seubert C., Barbour R., Blomquist C., Lee M., Lee D., Coria F., Chang L., Miller B., Lieberburg I., Schenk D. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer disease. Neurology 1995; 45: 788–793
   PubMed Web of Science ®Google Scholar
• Vitek M.P., Bhattacharya K., Glendenning J.M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1994; 91: 4766–4770
   PubMed Web of Science ®Google Scholar
• Wallace D.C. Mitochondrial genetics: a paradigm for aging and degenerative diseases. Science 1992; 256: 628–632
   PubMed Web of Science ®Google Scholar
• Wallace D.C. Mitochondrial DNA sequence variation in human evolution and disease. Proceedings of the National Academy of Sciences, USA 1994; 91: 8739–8746
   PubMed Web of Science ®Google Scholar
• Wilcock G.K., Esiri M.M. Plaques, tangles and dementia: a quantitative study. Journal of Neurological Sciences 1982; 56: 407–417
   Google Scholar
• Wille H., Drewes G., Biernat J., Mandelkow E.-M., Mandelkow E. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. Journal of Cell Biology 1992; 118: 573–584
   PubMed Web of Science ®Google Scholar
• Wischik C.M., Novak M., Thøgersen H.C., Edwards P.C., Runswick M.J., Jakes R., Walker J.E., Milstein C., Roth M., Klug A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1988; 85: 4506–4510
   PubMed Web of Science ®Google Scholar
• Wischik C.M., Edwards P.C., Lai R.Y.K., Gertz H.-J., Xuereb J.H., Paykel E.S., Brayne C., Huppert F.A., Mukaetova-Ladinska E.B., Mena R., Roth M., Harrington C.R. Quantitative analysis of tau protein in paired helical filament preparations: implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease. Neurobiology of Aging 1995a; 16: 409–431
   PubMed Web of Science ®Google Scholar
• Wischik C.M., Edwards P.C., Harrington C.R. The tau protein amyloidosis of Alzheimer's disease: its mechanisms, potential trigger factors and consequences. Neurobiology of Alzheimer's disease, D. Dawbarn, S.J. Allen. BIOS Scientific Publishers, Oxford 1995b; 89–148
   Google Scholar
• Wisniewski H.M. No evidence for aluminum in etiology and pathogenesis of Alzheimer's disease. Neurobiology of Aging 1986; 7: 532–535
   PubMed Web of Science ®Google Scholar
• Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neuroscience Letters 1992; 135: 235–238
   PubMed Web of Science ®Google Scholar
• Yamamoto H., Saitoh Y., Yasugawa S., Miyamoto E. Dephosphorylation of factor by protein phosphatase 2A in synaptosomal cytosol fractions, and inhibition by aluminium. Journal of Neurochemistry 1990; 55: 683–690
   PubMed Web of Science ®Google Scholar
• Yan S.-D., Chen X., Schmidt A.-M., Brett J., Godman G., Zou Y.-S., Scott C.W., Caputo C., Frappier T., Smith M.A., Perry G., Yen S.H., Stern D. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proceedings of the National Academy of Sciences, USA 1994; 91: 7787–7791
   PubMed Web of Science ®Google Scholar
• Yan S.D., Yan S.F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M.A., Perry G., Godman G.C., Nawroth P., Lweier J.L., Stern D. Non-enzymaucally glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Medicine 1995; 1: 693–699
   PubMed Web of Science ®Google Scholar